Birt-Hogg-Dubé Newsletter December 2014 Vol.13, No.4 You are receiving this email because you have expressed an interest in BHD. We hope you will enjoy this and

First Page		Document Content
Date: 2014-12-10 06:54:19 Birt–Hogg–Dubé syndrome Renal cell carcinoma Kidney tumour Folliculin Pneumothorax Metastasis Birt BHD Oncocytoma Medicine Kidney cancer Health		Birt-Hogg-Dubé Newsletter December 2014 Vol.13, No.4 You are receiving this email because you have expressed an interest in BHD. We hope you will enjoy this and Add to Reading List Source URL: www.bhdsyndrome.org Download Document from Source Website File Size: 37,04 KB Share Document on Facebook

	#4503 A Small Molecule Glycomimetic Antagonist of E-selectin (GMIPrevents Pancreatic Tumor Metastasis and Offers Improved Efficacy of Chemotherapy Maria M. Steele1, BS, Prakash Radhakrishnan1, PhD, John L. Magnani DocID: 1vkKU - View Document
	Quantitative image-based phenotypes for cancer metastasis systems biology Joel S. Bader, Ph.D. Professor, Biomedical Engineering Johns Hopkins University DocID: 1vd8y - View Document
	A small molecule glycomime.c antagonist of E-‐selec.n and CXCR4 (GMI-‐1359) delays pancrea.c tumor metastasis and signiﬁcantly alters the DocID: 1uubq - View Document
	Why we focus on Metastasis & Invasion Around 90% of cancer deaths are attributable to invasion and metastasis. Metastasis is the spread of disease from one organ or part to another not directly connected with the primary DocID: 1sjoH - View Document
	Nota de Prensa LA FDA APRUEBA DENOSUMAB PARA LA PREVENCIÓN DE EVENTOS ESQUELÉTICOS EN PACIENTES CON METÁSTASIS ÓSEAS DE TUMORES SÓLIDOS BARCELONA. (nov. 19, 2010) – La FDA ha aprobado denosumab, el primer y DocID: 1s5nh - View Document